SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-178582
Filing Date
2015-05-08
Accepted
2015-05-08 09:26:17
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d913777d10q.htm 10-Q 285577
2 EX-31.1 d913777dex311.htm EX-31.1 6181
3 EX-31.2 d913777dex312.htm EX-31.2 6316
4 EX-32.1 d913777dex321.htm EX-32.1 3552
5 EX-32.2 d913777dex322.htm EX-32.2 3513
  Complete submission text file 0001193125-15-178582.txt   2846757

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT flxn-20150331.xml EX-101.INS 338987
7 XBRL TAXONOMY EXTENSION SCHEMA flxn-20150331.xsd EX-101.SCH 29251
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flxn-20150331_cal.xml EX-101.CAL 55436
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flxn-20150331_def.xml EX-101.DEF 56436
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20150331_lab.xml EX-101.LAB 243898
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20150331_pre.xml EX-101.PRE 164923
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36287 | Film No.: 15844694
SIC: 2834 Pharmaceutical Preparations